Theragen Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -99.59%
- Profit Growth -161.82%
- Ebitda -197.33%
- Net Worth -83.34%
- Total Assets 80.06%
About Theragen Lifesciences
Theragen Lifesciences Private Limited (TLPL) is a Private Limited Indian Non-Government Company incorporated in India on 16 May 2017 (Seven years and eight months 17 days old ). Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Andal Arumugam and Arumugam Sivaraman serve as directors at the Company.
Company Details
-
Location
Chennai, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85300TN2017PTC116538
-
Company No.
116538
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
16 May 2017
-
Date of AGM
26 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
What products or services does Theragen Lifesciences Private Limited offer?
Theragen Lifesciences Private Limited offers a wide range of products and services, including BPO Operations and Services, BPO Services, Pharma & Bioanalytical Services, Pharmaceutical Services.
Who are the key members and board of directors at Theragen Lifesciences?
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Andal Arumugam | Director | 16-May-2017 | Current |
Arumugam Sivaraman | Director | 16-May-2017 | Current |
Financial Performance of Theragen Lifesciences.
Theragen Lifesciences Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 99.59% decrease. The company also saw a substantial fall in profitability, with a 161.82% decrease in profit. The company's net worth observed a substantial decline by a decrease of 83.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Theragen Lifesciences?
In 2019, Theragen Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Theragen Lifesciences?
Theragen Lifesciences has a workforce of 21 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Theragen Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Theragen Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.